Curis, Inc. (CRIS) Reports Second Quarter 2013 Financial Results
8/5/2013 9:33:25 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LEXINGTON, Mass., Aug. 5, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS), an oncology-focused drug development company seeking to develop novel drug candidates for the treatment of human cancers, today reported its financial results for the second quarter ended June 30, 2013.
Help employers find you! Check out all the jobs and post your resume.
comments powered by